Research News

Macular Degeneration Research

Nearly 20 million adults in the U.S. have some form of age-related macular degeneration, almost double the previous estimate of 11 million people, according to a new report. Learn why.

Jan 3, 2023
Alzheimer's Disease Research

A new blood test that could facilitate a more accurate diagnosis of Alzheimer’s during the initial phases of the disease is on the way—rooted in critical early support from Alzheimer’s Disease Research, a program of BrightFocus Foundation. Catching the disease as soon as possible offers affected individuals the greatest gift of all—more time to spend with loved ones and explore disease management and treatment options.

Dec 6, 2022
National Glaucoma Research

A team of BrightFocus-funded scientists has proposed a new explanation and possible new target for treatment in glaucoma that’s unrelated to the common culprit of eye pressure.

Dec 1, 2022
Macular Degeneration Research

David Liao, MD, offers insights into managing and understanding AMD and what forthcoming FDA approval could mean for treatment.

Nov 30, 2022
Alzheimer's Disease Research

Clinical trial results released Nov. 29 for lecanemab, a drug targeting early Alzheimer’s disease, reported a moderate slowing of cognitive decline in patients by 25% through the removal of amyloid-beta (Aβ) in the brain.

Nov 30, 2022
Macular Degeneration Research

If approved, the drug pegcetacoplan would become the first-ever treatment in the U.S. for geographic atrophy, a blinding and advanced form of age-related macular degeneration.

Nov 21, 2022
Alzheimer's Disease Research

Gael Chetelat, PhD, University of Caen-Normandy, France, was honored on Oct. 21, 2022, by Women’s Health Access Matters for her BrightFocus-funded project, “Sex Differences in Risk Profiles Across the Alzheimer’s Disease Continuum.”

Nov 15, 2022
Alzheimer's Disease Research

A recent article coauthored by BrightFocus Vice President, Scientific Affairs Diane Bovenkamp, PhD, proposes a new way to narrow racial and ethnic disparities in Alzheimer’s research through the development of standardized electronic health records.

Oct 27, 2022
National Glaucoma Research

Jason Meyer, PhD, is a BrightFocus Foundation success story and a pioneer in the effort to regenerate eye tissue that is damaged by glaucoma. 

Sep 29, 2022
Alzheimer's Disease Research

New BrightFocus-funded research explores how a protein called tau, critical to Alzheimer’s, turns from normal to a diseased state. This discovery presents a new target to potentially prevent or treat Alzheimer's disease.

Sep 22, 2022